‘Floating lotus’ sign spotted: could prevent unnecessary procedure cancellations in AFib patients
NCT ID NCT07439731
First seen Mar 31, 2026 · Last updated Jun 16, 2026 · Updated 11 times
Summary
This study looked at 172 people with atrial fibrillation who had a heart procedure guided by a special ultrasound. Researchers found a common harmless imaging artifact, called the 'Floating Lotus' sign, that can look like a dangerous blood clot. By learning to tell the difference, doctors can avoid canceling procedures or changing blood thinners unnecessarily.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Shidong Hospital, Yangpu District
Shanghai, Shanghai Municipality, 200438, China
-
The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital)
Shanghai, Shanghai Municipality, 200433, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.